Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/29618
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDrewett, George P-
dc.contributor.authorEncena, Jess-
dc.contributor.authorGregory, Joy-
dc.contributor.authorFranklin, Lucinda-
dc.contributor.authorTrubiano, Jason-
dc.date2022-03-21-
dc.date.accessioned2022-03-31T22:49:43Z-
dc.date.available2022-03-31T22:49:43Z-
dc.date.issued2022-06-06-
dc.identifier.citationThe Medical journal of Australia 2022; 216(10): 520-524en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/29618-
dc.description.abstractTo investigate the causes, characteristics, and outcomes of anaphylaxis, particularly drug-related anaphylaxis, in Victoria during the first two years of mandatory notification. Review of all anaphylaxis cases reported by emergency departments to the Victorian Department of Health and Human Services. People presenting to all public and private hospital emergency departments in Victoria, 1 November 2018 - 31 December 2020. Rates of drug- and food-related anaphylaxis, by age group; characteristics of cases of drug-related anaphylaxis. A total of 4273 anaphylaxis episodes were reported (females: 2292 cases, 54%); the overall anaphylaxis rate was 31.9 episodes per 100 000 person-years. The most frequently reported causes were foods (2659 cases, 62%); drugs were implicated in 533 cases (12%), insect venoms in 342 (8%), and other causes in 144 (4%). No deaths were recorded. The median age in cases of food-related anaphylaxis was 17 years (IQR, 6-29 years), and 45 years (IQR, 30-60 years) in cases of drug-related anaphylaxis. Hospitalisation was required by 1538 patients (36%) and intensive care by 111 (2.6%; 7% of people admitted to hospital). Antimicrobial drugs were implicated in 258 cases of drug-related anaphylaxis (48%) and non-steroidal anti-inflammatory drugs in 85 cases (16%). Penicillin-class agents were implicated in 143 cases of antimicrobial-related anaphylaxis (56%), cephalosporins in 80 cases (31%). Our review of notified cases of anaphylaxis in Victoria over two years provides insights into drug- and antimicrobial-related anaphylaxis in non-hospitalised people presenting to emergency departments.en
dc.language.isoeng-
dc.subjectAnaphylaxisen
dc.subjectCommunity careen
dc.subjectDrug hypersensitivityen
dc.titleAnaphylaxis in Victoria: presentations to emergency departments, with a focus on drug- and antimicrobial-related cases.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Medical journal of Australiaen
dc.identifier.affiliationAustin Healthen
dc.identifier.affiliationVictorian Department of Health, Melbourne, Victoria, Australia..en
dc.identifier.affiliationPeter MacCallum Cancer Institute, Melbourne, Victoria, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35307833/en
dc.identifier.doi10.5694/mja2.51459en
dc.type.contentTexten
dc.identifier.orcidhttps://orcid.org/0000-0002-9439-0251en
dc.identifier.orcidhttps://orcid.org/0000-0002-5111-6367en
dc.identifier.pubmedid35307833-
local.name.researcherDrewett, George P-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptCOVID-19 Screening Clinic-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

48
checked on Dec 17, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.